'Foreign Patient Attraction Platform' HiMedi Surpasses 10,000 Subscribers

[Asia Economy Reporter Lim Jeong-su] Haimedi, a company attracting foreign patients, announced on the 5th that the number of platform subscribers has surpassed 10,000.

Haimedi introduced Korea's first medical concierge services including interpretation, accommodation, and transportation for Middle Eastern patients in 2011, and launched a foreign patient attraction platform in August 2020.

The majority of subscribers are severe patients from Mongolia, the Middle East, and Kazakhstan. Since June last year, when they officially started non-face-to-face medical services for patients who had difficulty visiting Korea due to COVID-19, the number of subscribers has rapidly increased. The number of non-face-to-face requests exceeded 3,700 within six months of the service opening, and the cumulative number of requests to date is 4,700.

In particular, since the target is severe patients who find it difficult to receive treatment in their home countries, the rate of entering Korea for proper treatment after non-face-to-face medical consultation is very high.

Last year, the average medical expense per patient who entered Korea for surgery after non-face-to-face consultation through Haimedi was 17 million KRW. The highest amount was 100 million KRW for colorectal cancer surgery, and the lowest amount was about 10 million KRW for brain tumor surgery.

The diseases with the highest number of non-face-to-face medical requests were female diseases such as infertility, uterine fibroids, and gynecologic cancers. Orthopedic diseases such as spine and joints, and internal medicine diseases such as cancer and tumors followed.

Seodon Kyo, co-CEO of Haimedi, said, "Haimedi's customers are mostly severe foreign patients who urgently need Korean medical services, so we were able to grow rapidly even during the pandemic. We will be a foreign patient attraction platform that provides good solutions not only for patients who find it difficult to receive quality treatment in their home countries but also for domestic hospitals whose revenues have deteriorated due to COVID-19."

Meanwhile, Haimedi plans to expand its services to Southeast Asia and English-speaking countries, where demand for severe diseases as well as plastic surgery and beauty is high, to increase Korea's market share in the global foreign patient attraction market worth 100 trillion KRW annually. The current main target countries are the Commonwealth of Independent States including Russia and Kazakhstan, as well as Mongolia, Russia, and the Middle East.

This content was produced with the assistance of AI translation services.